citalopram has been researched along with Diabetes Mellitus, Type 2 in 9 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Fluoxetine and Citalopram can effectively reduce the severity of depression in diabetic patients without an adverse effect on glycemic control." | 9.15 | Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? ( Khazaie, H; Najafi, F; Rahimi, M; Rezaei, M; Tahmasian, M; Tatari, F, 2011) |
| "5 years) who had a major depressive disorder diagnosed with a Beck Depression Inventory (BDI) test score greater than 16 and confirmed with a structured interview, were prescribed citalopram 20mg once daily." | 5.17 | Treatment of depression in type 2 diabetic patients: effects on depressive symptoms, quality of life and metabolic control. ( Chacártegui, B; Francés, C; Masmiquel, L; Nicolau, J; Rivera, R, 2013) |
| "Fluoxetine and Citalopram can effectively reduce the severity of depression in diabetic patients without an adverse effect on glycemic control." | 5.15 | Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram? ( Khazaie, H; Najafi, F; Rahimi, M; Rezaei, M; Tahmasian, M; Tatari, F, 2011) |
| " Due to many contradictory findings on the adverse effects and toxicities of SSRIs (especially genotoxicities), we reviewed the genotoxic effects of these drugs." | 2.72 | A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors. ( Abbaszadegan, MR; Ahmadimanesh, M; Hedayati, N; Jamialahmadi, T; Sahebkar, A; Yazdian-Robati, R, 2021) |
| "Escitalopram showed lower fasting and post-lunch blood sugar values on follow up, which was clinically and statistically significant." | 1.39 | Depression and diabetes: impact of antidepressant medications on glycaemic control. ( Agari, AD; Dhavale, HS; Ghulghule, M; Jadhav, BS; Panikkar, V, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, TXD | 1 |
| Filliter, C | 1 |
| Montastruc, F | 1 |
| Yu, OHY | 1 |
| Fergusson, E | 1 |
| Rej, S | 1 |
| Azoulay, L | 1 |
| Renoux, C | 1 |
| Ahmadimanesh, M | 1 |
| Abbaszadegan, MR | 1 |
| Hedayati, N | 1 |
| Yazdian-Robati, R | 1 |
| Jamialahmadi, T | 1 |
| Sahebkar, A | 1 |
| Nicolau, J | 1 |
| Rivera, R | 1 |
| Francés, C | 1 |
| Chacártegui, B | 1 |
| Masmiquel, L | 1 |
| Dhavale, HS | 1 |
| Panikkar, V | 1 |
| Jadhav, BS | 1 |
| Ghulghule, M | 1 |
| Agari, AD | 1 |
| An, Z | 1 |
| Moore, MC | 1 |
| Winnick, JJ | 1 |
| Farmer, B | 1 |
| Neal, DW | 1 |
| Lautz, M | 1 |
| Smith, M | 1 |
| Rodewald, T | 1 |
| Cherrington, AD | 1 |
| Derijks, HJ | 1 |
| Janknegt, R | 1 |
| Heerdink, ER | 1 |
| De Koning, FH | 1 |
| Krekels, MM | 1 |
| Looij, BJ | 1 |
| Egberts, AC | 1 |
| Trento, M | 1 |
| Kucich, C | 1 |
| Tibaldi, P | 1 |
| Gennari, S | 1 |
| Tedesco, S | 1 |
| Balbo, M | 1 |
| Arvat, E | 1 |
| Cavallo, F | 1 |
| Ghigo, E | 1 |
| Porta, M | 1 |
| Khazaie, H | 1 |
| Rahimi, M | 1 |
| Tatari, F | 1 |
| Rezaei, M | 1 |
| Najafi, F | 1 |
| Tahmasian, M | 1 |
| Nabbi, R | 1 |
| Riess, ML | 1 |
| Woehlck, HJ | 1 |
1 review available for citalopram and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors.
Topics: Citalopram; Diabetes Mellitus, Type 2; DNA Damage; Humans; Paroxetine; Selective Serotonin Reuptake | 2021 |
3 trials available for citalopram and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Treatment of depression in type 2 diabetic patients: effects on depressive symptoms, quality of life and metabolic control.
Topics: Aged; Antidepressive Agents, Second-Generation; Citalopram; Depression; Diabetes Mellitus, Type 2; D | 2013 |
A study of central serotoninergic activity in healthy subjects and patients with Type 2 diabetes treated by traditional one-to-one care or Group Care.
Topics: Antidepressive Agents; Central Nervous System; Citalopram; Depression; Diabetes Mellitus, Type 2; Fe | 2010 |
Treatment of depression in type 2 diabetes with Fluoxetine or Citalopram?
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Blood Glucose; Chi-Square Distribution; Cital | 2011 |
5 other studies available for citalopram and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Hu | 2022 |
Depression and diabetes: impact of antidepressant medications on glycaemic control.
Topics: Adolescent; Adult; Antidepressive Agents; Blood Glucose; Citalopram; Depression; Diabetes Mellitus, | 2013 |
Portal infusion of escitalopram enhances hepatic glucose disposal in conscious dogs.
Topics: Animals; Antidepressive Agents, Second-Generation; Carbon; Citalopram; Diabetes Mellitus, Type 2; Do | 2009 |
Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.
Topics: Adult; Aged; Antidepressive Agents; Biomarkers; Citalopram; Depression; Diabetes Mellitus, Type 1; D | 2009 |
Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue.
Topics: Aged; Angiotensin Receptor Antagonists; Carbazoles; Carvedilol; Citalopram; Crystalloid Solutions; D | 2012 |